Smarter care,
affordable products,
strategic capital
Mordelt builds AI-powered healthcare infrastructure, distributes essential generic medicines, and deploys capital into the companies reshaping how care is delivered — across the UK and West Africa.
AI Platform
AI-powered primary care triage and chronic disease management — high need, low competition in West Africa, proven playbook in the UK. Our ambient documentation and clinical decision support tools reduce diagnostic time and administrative waste.
Products
Essential generic drugs around metabolic health — diabetes, hypertension, obesity management. Massive prevalence in Nigeria, fragmented supply chains. We consolidate distribution and guarantee quality at scale.
Investments
Backing listed and private Healthcare IT and medtech companies. Provider software deal value doubled in 2025 to $32B. We deploy into analytics, workflow automation, and platform solutions across the care continuum.
The market is moving
Healthcare IT deal value within the provider segment doubled in 2025 to an estimated $32 billion. Women's health remains the best underappreciated opportunity — an investment arbitrage. Care is migrating closer to the patient, and AI is eliminating administrative waste at scale.
Essential medicines, at scale
Generic drugs around metabolic health address the highest-prevalence conditions in West Africa — diabetes and hypertension alone affect tens of millions. We consolidate fragmented supply chains and deliver quality generics where they're needed most.
View full formularyWhere we deploy capital
We back listed and private Healthcare IT, medtech, and women's health companies — the sectors with the strongest structural tailwinds and most durable returns in the 2025–2030 cycle.
Healthcare IT & Provider Software
Analytics, workflow automation, and platform solutions. Provider segment deal value doubled in 2025 — this is the most active segment in healthcare venture.
Women's Health
Historically underinvested despite massive unmet need — fertility, menopause, and broader care models spanning cardiology, oncology, and immunology. A clear investment arbitrage.
Care-at-Home & Longevity
Care delivery is migrating closer to the patient. GLP-1 adjacency — obesity management, metabolic health apps, preventative diagnostics — is noisy but structurally real.
Common questions
Mordelt operates across three integrated arms: an AI-powered healthcare platform for primary care triage and chronic disease management, a generic medicines distribution business focused on metabolic health, and a capital deployment arm investing in Healthcare IT and medtech companies.
The UK provides a proven regulatory and digital health playbook. West Africa has over 400 million people underserved by primary care infrastructure, massive prevalence of metabolic diseases like diabetes and hypertension, and highly fragmented pharmaceutical supply chains. The combination offers both a tested model and a vast addressable market.
Our platform combines clinical triage AI, ambient documentation, and workflow automation to reduce diagnostic time and administrative burden. It's designed for primary care and chronic disease management — the highest-volume, highest-waste areas of healthcare delivery.
We deploy capital into Healthcare IT, women's health, and care-at-home — the sectors with the strongest structural tailwinds. AI represents 46% of all healthcare VC. Provider software deal value doubled in 2025. Women's health is explicitly classified as an investment arbitrage opportunity. We invest where the cycle is early and the returns are durable.
We work with pharmaceutical distributors, healthcare providers, technology partners, and institutional investors. Reach out through our contact form and our partnerships team will follow up within 48 hours.
For information about our current fundraising status and investment opportunities, please get in touch directly. We selectively engage with aligned institutional and strategic partners.
Get in touch
Whether you're a provider, distributor, investor, or technology partner — we'd like to hear from you. Our team responds within 48 hours.